Kadmon (KDMN) – Trading Halts
-
Kadmon (KDMN) to Resume Trading at 2:45 p.m.
-
Kadmon (KDMN) Announces U.S. FDA Grants Full Approval of REZUROCK (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease
-
Back to KDMN Stock Lookup